Using different cytokines, such as IL-6, IL-13, or LPS, it could generate BM-MDSCs in vitro and successfully treated diseases in vivo, like graft-versus-host disease, skin transplantation and pancreatic islet transplantation (22, 23, 42, 43). This evidence concerns the gene IL13 and graft versus host disease.